Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Contract Research Organization
Regulatory, Tech Transfer & Support Services
Company Overview
About
Evotec is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Neurology
Quick Facts
HQ:Germany
Founded:2018
Employees:501
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Asia-Pacific
Manufacturing Facilities
1 site worldwide
DAPIN GmbH
Kantstrasse 2, Halle (Westphalia), 33790
Site Capabilities
1 capabilityAPI MANUFACTURE
International Regulatory
EU GMP Certificates
1
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval Z42EZV
FDA · #APR-QFTDL67S · 2021-03-01
Drug Approval F224YA
FDA · #APR-PT35MINC · 2022-07-01
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-5SXF6DXQ
Issued: 2020-01-02
Expires: 2025-01-27
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-9J7RU64A
Issued: 2020-02-28
Expires: 2025-12-07
Loading CDMO intelligence...
Key facts about Evotec
- Evotec is headquartered in Germany.
- Evotec was founded in 2018.
- Evotec has 501 employees.
- Evotec has one manufacturing site listed on CDMO Hub, in Halle (Westphalia), Germany.
- Evotec's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Evotec
Directory pages this company appears in, each with the full list of matching manufacturers.